UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis

Alternative therapies in health and medicine, 2001-05, Vol.7 (3), p.79

2001

Volltextzugriff (PDF)

Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas

The American journal of pathology, 1997-06, Vol.150 (6), p.2143-2152

1997

Volltextzugriff (PDF)

A Double-Blind, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of CP-101,606 in Patients with a Mild or Moderate Traumatic Brain Injury

Annals of the New York Academy of Sciences, 1999-01, Vol.890 (1), p.42-50

1999

Volltextzugriff (PDF)

An Open-Label Study of CP-101,606 in Subjects with a Severe Traumatic Head Injury or Spontaneous Intracerebral Hemorrhage

Annals of the New York Academy of Sciences, 1999-01, Vol.890 (1), p.51-58

1999

Volltextzugriff (PDF)

IL-6 Secretion by a Rat T9 Glioma Clone Induces a Neutrophil-Dependent Antitumor Response with Resultant Cellular, Antiglioma Immunity

The Journal of immunology (1950), 2001-01, Vol.166 (1), p.121-129

2001

Volltextzugriff (PDF)

Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats

Journal of neuro-oncology, 1999-01, Vol.45 (3), p.209-218

1999

Volltextzugriff (PDF)

Toward Precision and Reproducibility of Diffusion Tensor Imaging: A Multicenter Diffusion Phantom and Traveling Volunteer Study

American journal of neuroradiology : AJNR, 2017-03, Vol.38 (3), p.537-545

2017

Volltextzugriff (PDF)

Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin‐2

Cancer, 1988-08, Vol.62 (4), p.665-671

1988

Volltextzugriff (PDF)

Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or combination with systemic interferon-α. Results of a phase I clinical trial

Journal of neuro-oncology, 1992, Vol.12 (1), p.75-83

1992

Volltextzugriff (PDF)

Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-α in the rat

Journal of neuro-oncology, 1994-01, Vol.20 (1), p.17-25

1994

Volltextzugriff (PDF)

Effects of an intratumoral injection of human recombinant tumor necrosis factor-α on cerebrovascular permeability and leukocytic infiltration in a rat glioma model

Acta neuropathologica, 1997, Vol.93 (1), p.78-86

1997

Volltextzugriff (PDF)

Impact of historical land-use changes on greenhouse gas exchange in the U.S. Great Plains, 1883-–2003

Ecological applications, 2011-06, Vol.21 (4), p.1105-1119

2011

Volltextzugriff (PDF)

Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis

Cancer Immunology, Immunotherapy, 2001-08, Vol.50 (6), p.285-292

2001

Volltextzugriff (PDF)

Glioma proliferation modulated in vitro by isothermal radiofrequency radiation exposure

Radiation research, 1990-01, Vol.121 (1), p.38

1990

Volltextzugriff (PDF)

Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression

Cancer Immunology, Immunotherapy, 2002-06, Vol.51 (4), p.190-199

2002

Volltextzugriff (PDF)

In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect

Journal of neurosurgery, 1992-02, Vol.76 (2), p.251-260

1992

Volltextzugriff (PDF)

Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats

Journal of neuroimmunology, 1991-09, Vol.33 (3), p.245-251

1991

Volltextzugriff (PDF)

Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination

Cancer Immunology, Immunotherapy, 2002-06, Vol.51 (4), p.179-189

2002

Volltextzugriff (PDF)

Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion

Cancer research (Chicago, Ill.), 1987-11, Vol.47 (21), p.5765-5770

1987

Volltextzugriff (PDF)

Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-α in the rat

Acta neuropathologica, 1992, Vol.85 (1), p.93-100

1992

Volltextzugriff (PDF)

Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells

Immunology, 1989, Vol.66 (1), p.117-124

1989

Volltextzugriff (PDF)

Distribution of adoptively transferred, tumor-sensitized lymphocytes in the glioma-bearing rat

Journal of neuro-oncology, 2002-11, Vol.60 (2), p.143-150

2002

Volltextzugriff (PDF)

Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery

Journal of neuroimmunology, 2003-07, Vol.140 (1), p.49-60

2003

Volltextzugriff (PDF)

Cardiopulmonary effects of recombinant interleukin-2 infusion in sheep

Journal of applied physiology (1985), 1988-03, Vol.64 (3), p.1030-1037

1988

Volltextzugriff (PDF)

Systemic treatment with murine recombinant interleukin-1β inhibits the growth and progression of malignant glioma in the rat

Journal of neuro-oncology, 1992-05, Vol.13 (1), p.43-55

1992

Volltextzugriff (PDF)

1 – 25 von 932

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(838)
Mit Volltextzugriff
(770)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis

Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas

A Double-Blind, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of CP-101,606 in Patients with a Mild or Moderate Traumatic Brain Injury

An Open-Label Study of CP-101,606 in Subjects with a Severe Traumatic Head Injury or Spontaneous Intracerebral Hemorrhage

IL-6 Secretion by a Rat T9 Glioma Clone Induces a Neutrophil-Dependent Antitumor Response with Resultant Cellular, Antiglioma Immunity

Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats

Toward Precision and Reproducibility of Diffusion Tensor Imaging: A Multicenter Diffusion Phantom and Traveling Volunteer Study

Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin‐2

Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or combination with systemic interferon-α. Results of a phase I clinical trial

Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-α in the rat

Effects of an intratumoral injection of human recombinant tumor necrosis factor-α on cerebrovascular permeability and leukocytic infiltration in a rat glioma model

Impact of historical land-use changes on greenhouse gas exchange in the U.S. Great Plains, 1883-–2003

Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis

Glioma proliferation modulated in vitro by isothermal radiofrequency radiation exposure

Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression

In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect

Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats

Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination

Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion

Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-α in the rat

Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells

Distribution of adoptively transferred, tumor-sensitized lymphocytes in the glioma-bearing rat

Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery

Cardiopulmonary effects of recombinant interleukin-2 infusion in sheep

Systemic treatment with murine recombinant interleukin-1β inhibits the growth and progression of malignant glioma in the rat

Suchergebnisse filtern